単細胞マルチオミクスによる白血病幹細胞の異質性と可塑性の解消
Frank Y Huang1, Andreas Trumpp2, Patrick Stelmach2
1Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM, gGmbH), Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
Seminars in hematology
|September 5, 2025
まとめ
白血病幹細胞 (LSC) は急性骨髄性白血病 (AML) の再発を促し,非常に多様です. 単細胞マルチオミクスは,よりよいAML診断と治療のためにLSCの異質性を理解するのに役立ちます.
科学分野:
- 血液学
- 癌 生物学
- ゲノミクス
背景:
- 急性骨髄性白血病 (AML) は,様々な白血病幹細胞 (LSC) によって引き起こされます.
- LSCの異質性は,治療反応と疾患再発に影響する.
- LSCの多様性を理解することは,効果的なAML治療に不可欠です.
研究 の 目的:
- AMLにおけるLSCの異質性の原因と結果を検討する.
- LSCの多様性を解剖するための単細胞マルチオミクスの進歩を強調する.
- これらの技術がAMLの診断とモニタリングを改善する方法を探る.
主な方法:
- 最近の科学文献のレビュー
- 単細胞マルチオミクス技術 (ゲノミクス,トランスクリプトミクス,表遺伝子ミクス,プロテオミクス) に焦点を当てる.
- AMLにおけるLSCの異質性と可塑性の分析
主要な成果:
- LSCの異質性は遺伝的および非遺伝的要因から生じる.
- 単細胞マルチオミクスは,個々のLSCの高解像度の分子スナップショットを提供します.
- この技術はLSCの状態と脆弱性をより深く理解することを可能にします.
結論:
- LSCの異質性は AMLにおける課題であり 治療の機会でもあります
- 単細胞マルチオミクスは AML LSCの多様性の研究を変革しています
- これらの技術の進歩は AMLの診断と 患者のモニタリングに革命をもたらします
関連する概念動画
01:19Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
01:15Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
01:21Lineage Commitment
3.1K
Commitment is the process whereby stem cells:
3.1K
02:40Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K